Investing Profile

Alexander Mayweg

InvestorVC
Managing Director at Versant Ventures
versantventures.com/team/alex...Basel, Switzerland
Photo of Alexander Mayweg, Managing Director at Versant Ventures
Your Intro Paths to Alexander Mayweg

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Networks Alexander is a member of
Stanford University Network
1276 CONNECTIONS
Alex & Thiago Network
499 CONNECTIONS
University of Oxford Network
370 CONNECTIONS
Imperial College London Network
163 CONNECTIONS
Roche Network
47 CONNECTIONS

Find Alexander Mayweg on

cb
Current Investing Position
Versant Ventures Managing Director
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M
Investments On Record
18
Current Fund Size
$102.2M

Alexander Mayweg is on these Sector & Stage Rankings

Alexander Mayweg's Investments On Record (11)

CompanyStageDateRound SizeTotal Raised
Antag Therapeutics
Series ADec 2024$84M
$84M
Bright Peak Therapeutics
Series CJun 2024$90M
Series BJun 2021$110M
Series AJul 2020$35M
$230M
Co-investors: Tom Woiwode (Versant Ventures), Josh Resnick
SixPeaks Bio
Series AMay 2024$30M
$30M
Launchpad Therapeutics
Series ADec 2022$30M
$30M
Co-investors: Ali Behbahani (New Enterprise Associates (NEA))
Vector BioPharma
Series AAug 2022$30M
$30M
Cimeio Therapeutics
Series AApr 2022$50M
$50M
T-knife
Series BAug 2021$110M
Series AAug 2020$78M
$200M
Co-investors: Olivier Litzka (Andera Partners)
Monte Rosa Therapeutics
Series CMar 2021$95M
Series BSep 2020$96M
Series AMay 2020$33M
$220M
Co-investors: Ali Behbahani (New Enterprise Associates (NEA)), David Schenkein (GV (Google Ventures)), Issi Rozen (GV (Google Ventures)), Andrew Schiff (Aisling Capital), Markus Warmuth (Versant Ventures), Chandra Leo (HBM Partners AG)

Alexander Mayweg's Experience

Laboratory Head, Medicinal Chemistry | Scientist RochePresent
Project Leader, Research Informatics (Additional Responsibility) | Senior Scientist RochePresent
Project Leader, Medicinal Chemistry | Senior Scientist RochePresent
Group Leader, Medicinal Chemistry | Principal Scientist RochePresent
Short Term International Assignment RochePresent
Site Head of Medicinal Chemistry | Senior Leader RochePresent
Section Head in Discovery Chemistry Technologies & Metabolic Diseases | Leader RochePresent
Head of Antibiotics Disease Area (Additional Responsibility) | Senior Leader RochePresent
Global Head of Medicinal Chemistry | Principal Leader, VP RochePresent
Entrepreneur in Residence Versant VenturesPresent
Founding CSO Black Diamond TherapeuticsPresent
Board Director Black Diamond TherapeuticsPresent
President and CSO Ridgeline DiscoveryPresent
Board Member Bright Peak TherapeuticsPresent
Board Director Enterprise TherapeuticsPresent
Board Director Monte Rosa TherapeuticsPresent
Managing Director Versant VenturesPresent
President of the Board of Directors Granite BioPresent
President of the Board of Directors SixPeaks BioPresent
Chairman of the Board Alex & ThiagoPresent
President of the Board of Directors Red Ridge BioPresent
President of the Board of Directors Serac BiosciencesPresent
Co-Founder Launchpad TherapeuticsPresent
Venture Partner Versant VenturesPresent
Partner Versant VenturesPresent

Alexander Mayweg's Education

Imperial College London B.Sc. Chemistry with a Year in Industry
University of Oxford D.Phil. Organic Chemistry
Stanford University Post Doc Organic Chemistry

Investors who invest with Alexander Mayweg

Sign in with Google →

Scouts & Angels Affiliated With Alexander Mayweg

Sign in with Google →